These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 28359621)

  • 41. Persistence of immunity to varicella-zoster virus after vaccination of healthcare workers.
    Saiman L; LaRussa P; Steinberg SP; Zhou J; Baron K; Whittier S; Della-Latta P; Gershon AA
    Infect Control Hosp Epidemiol; 2001 May; 22(5):279-83. PubMed ID: 11428437
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Seroepidemiology of varicella in Hangzhou, China in the vaccine era.
    Xu Y; Liu S; Che X; Liu Y; Zhang X; Du J; Zhang X; Wang J; Xu E
    Hum Vaccin Immunother; 2018; 14(10):2464-2471. PubMed ID: 30019992
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of vaccination on the epidemiology of varicella zoster virus.
    Edmunds WJ; Brisson M
    J Infect; 2002 May; 44(4):211-9. PubMed ID: 12099726
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Varicella zoster virus infection among healthcare workers in Taiwan: seroprevalence and predictive value of history of varicella infection.
    Wu MF; Yang YW; Lin WY; Chang CY; Soon MS; Liu CE
    J Hosp Infect; 2012 Feb; 80(2):162-7. PubMed ID: 22188630
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine.
    Watson B
    J Infect Dis; 2008 Mar; 197 Suppl 2():S143-6. PubMed ID: 18419388
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cellular immune response of a varicella vaccine following simultaneous DTaP and VZV vaccination.
    Habermehl P; Lignitz A; Knuf M; Schmitt HJ; Slaoui M; Zepp F
    Vaccine; 1999 Feb; 17(7-8):669-74. PubMed ID: 10067672
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The optimization and validation of the glycoprotein ELISA assay for quantitative varicella-zoster virus (VZV) antibody detection.
    Hammond O; Wang Y; Green T; Antonello J; Kuhn R; Motley C; Stump P; Rich B; Chirmule N; Marchese RD
    J Med Virol; 2006 Dec; 78(12):1679-87. PubMed ID: 17063506
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prospects for use of a varicella vaccine in adults.
    Hardy IR; Gershon AA
    Infect Dis Clin North Am; 1990 Mar; 4(1):159-73. PubMed ID: 2155261
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunity to varicella zoster virus in young Israeli adults.
    Avrahami-Heller Y; Cohen D; Orr N; Slepon R; Ashkenazi I; Danon YL
    Isr Med Assoc J; 2000 Mar; 2(3):196-9. PubMed ID: 10774265
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Seroepidemiology of varicella-zoster virus and reliability of varicella history in Turkish children, adolescents and adults.
    Koturoglu G; Kurugol Z; Turkoglu E
    Paediatr Perinat Epidemiol; 2011 Jul; 25(4):388-93. PubMed ID: 21649681
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunity to varicella zoster virus among pregnant women in the Norwegian Mother and Child Cohort Study.
    Mirinaviciute G; Barlinn R; Gjeruldsen Dudman S; Flem E
    PLoS One; 2019; 14(8):e0221084. PubMed ID: 31408478
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outbreak of varicella-zoster virus infection among Thai healthcare workers.
    Apisarnthanarak A; Kitphati R; Tawatsupha P; Thongphubeth K; Apisarnthanarak P; Mundy LM
    Infect Control Hosp Epidemiol; 2007 Apr; 28(4):430-4. PubMed ID: 17385149
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Primary vaccine failure after 1 dose of varicella vaccine in healthy children.
    Michalik DE; Steinberg SP; Larussa PS; Edwards KM; Wright PF; Arvin AM; Gans HA; Gershon AA
    J Infect Dis; 2008 Apr; 197(7):944-9. PubMed ID: 18419532
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The utility of serologic testing for varicella in an adolescent population.
    Ronan K; Wallace MR
    Vaccine; 2001 Sep; 19(32):4700-2. PubMed ID: 11535319
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Possibility of prevention of herpes zoster by use of varicella vaccine].
    Kawano S; Terada K; Yagi Y; Kataoka N
    Kansenshogaku Zasshi; 1998 Jul; 72(7):714-9. PubMed ID: 9745221
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Seroprevalence of varicella-zoster virus in Polish population.
    Siennicka J; Trzcińska A; Rosińska M; Litwińska B
    Przegl Epidemiol; 2009; 63(4):495-9. PubMed ID: 20120946
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reduced varicella-zoster-virus (VZV)-specific lymphocytes and IgG antibody avidity in solid organ transplant recipients.
    Prelog M; Schönlaub J; Jeller V; Almanzar G; Höfner K; Gruber S; Eiwegger T; Würzner R
    Vaccine; 2013 May; 31(20):2420-6. PubMed ID: 23583889
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vaccine effectiveness during a varicella outbreak among schoolchildren: Utah, 2002-2003.
    Haddad MB; Hill MB; Pavia AT; Green CE; Jumaan AO; De AK; Rolfs RT
    Pediatrics; 2005 Jun; 115(6):1488-93. PubMed ID: 15930208
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Abortive intrabronchial infection of rhesus macaques with varicella-zoster virus provides partial protection against simian varicella virus challenge.
    Meyer C; Engelmann F; Arnold N; Krah DL; ter Meulen J; Haberthur K; Dewane J; Messaoudi I
    J Virol; 2015 Feb; 89(3):1781-93. PubMed ID: 25410871
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Seroprevalence of varicella-zoster virus in the German population.
    Wutzler P; Färber I; Wagenpfeil S; Bisanz H; Tischer A
    Vaccine; 2001 Oct; 20(1-2):121-4. PubMed ID: 11567755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.